BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Oct. 12, 2005
View Archived Issues
Alzheimer's Drugs Could Follow New Breakthrough
Read More
Biovitrum Cutting Up To 100 Research Positions
Read More
AIM Wants To Fill Funding Gap For European Biotechs
Read More
Clarification
Read More
Avidex In-Licenses Antigen To Focus On Type I Diabetes
Read More
Other News To Note
Read More
Novexel Begins Phase I Trial, Gathers In Milestone Payment
PARIS - Novexel, a specialty pharmaceutical company, initiated a multidose Phase I trial of NXL 103, an orally administered antibiotic for the treatment of bacterial respiratory infections. (BioWorld International)
Read More
New Study Released Touting Global Benefits Of GM Crops
Read More